English

BioStock: Adjutec applies for phase I start

Report this content

Norwegian AdjuTec Pharma prepares for clinical trials with its concept for battling antimicrobial resistance. The company recently raised 16 MNOK and sent a clinical trial application to swedish autorities, aming to start phase I this summer. BioStock contacted CEO Bjørn Klem to get an update.

Read the full article at biostock.se:

https://www.biostock.se/2024/02/adjutec-applies-for-phase-i-start/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Subscribe

Documents & Links

Quick facts

BioStock: Adjutec applies for phase I start
Tweet this